The emergency use authorization (EUA) for a traditional herbal formula developed in Taiwan to treat COVID-19, known as Taiwan Chingguan Yihau (NRICM101), will be extended to June 2024, Health Minister Hsueh Jui-yuan (薛瑞元) said Sunday.
(Full text of the story is now in CNA English news archive. To view the full story, you will need to be a subscribed member of the CNA archive. To subscribe, please read here.)
More in CORONAVIRUS
Taiwan to shorten COVID-19 vaccine interval to 2 months for high-risk groupsThe Centers for Disease Control (CDC) announced Thursday that the required interval between two COVID-19 vaccine doses for high-risk groups will be shortened from six months to two months, effective next Wednesday.06/06/2025 08:17 PM
CDC confirms ample supply of COVID-19 drugs, vaccinesThe Centers for Disease Control (CDC) reiterated Sunday that Taiwan has sufficient antiviral medication for COVID-19 patients and emphasized the importance of vaccination, amid concerns raised by public figures.06/01/2025 06:13 PM
CDC issues COVID-19 warning as Dragon Boat Festival long weekend beginsMembers of the public should not let their guard down on COVID-19 and seek medical help if they experience symptoms that indicate risk of severe infection, the Centers for Disease Control (CDC) said Friday, the first day of the Dragon Boat Festival long weekend in Taiwan.05/30/2025 05:04 PM
Latest
- Business
Taiwanese startups' exports up 29.3% in 2025: MOEA
02/02/2026 07:03 PM - Society
Air quality alert issued in Taiwan as PM2.5 blows over from China
02/02/2026 06:29 PM - Politics
2nd Panamanian lawmaker group visits Taiwan in three months
02/02/2026 06:06 PM - Business
January car sales below estimate; February figure could fall further
02/02/2026 05:47 PM - Society
NGOs call on government to strengthen sex education in Taiwan
02/02/2026 05:28 PM


